Related Experiment Video
Updated: Jan 17, 2026
06:12
Virtual Prism Adaptation Therapy: Protocol for Validation in Healthy Adults
Published on: February 12, 2020
7.3K
Pragmatic trial of a virtual dementia collaborative care management program: protocol for the Aging Brain Care
Madison R Sauerteig-Rolston1,2, Nicole R Fowler3,2,4, Greg A Sachs3,2
1Department of Medicine, Division of General Internal Medicine and Geriatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA mrsauert@iu.edu.
BMJ Open
|September 23, 2025
Summary
This study evaluated a virtual dementia care program for Alzheimer's Disease and Related Dementias (ADRD) patients. The program aims to reduce healthcare utilization and improve medication management for patients and their care partners.
Area of Science:
- Gerontology
- Neurology
- Health Services Research
Background:
- Alzheimer's Disease and Related Dementias (ADRD) care presents significant challenges for health systems.
- The increasing prevalence of dementia necessitates scalable, community-based care solutions.
- Value-based care models require innovative approaches for managing complex patient needs.
Purpose of the Study:
- To evaluate the effectiveness of a virtual, evidence-based dementia collaborative care program.
- To assess the impact of the program on patient healthcare utilization and medication use.
- To explore implementation factors and outcomes through qualitative methods.
Main Methods:
- A 12-month, cluster-randomized controlled trial (Aging Brain Care Virtual - ABCV) across 24 primary care clinics.
- Enrollment of 860 persons living with dementia and their care partners.
- Virtual delivery of tailored care, measuring emergency department utilization and medication use via electronic health records.
Main Results:
- (Results not yet available as study is ongoing/data collection in progress)
Conclusions:
- (Conclusions will be drawn upon study completion and data analysis)
More Related Videos
Related Concept Videos
01:22Alzheimer's Disease: Treatment
825
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
825
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:30Cognitive Development During Adulthood
783
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
783
01:30Dementia
526
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
526
01:27Peripheral Artery Disease III: Interprofessional Care
248
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
248